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Bugs to the rescue
 
ugs that live in our gut are not only 
not harmful but provide signals that 
maintain gut tissue integrity, according to 
Seth Rakoff-Nahoum, Ruslan Medzhitov, 
and colleagues (Yale University, New 
Haven, CT).
The benefits of commensal, or non-
pathogenic gut bacteria, are well known. 
For example, these bacteria digest tricky 
carbohydrates and supply certain micro-
nutrients. But inappropriately enthusiastic 
responses to the bacteria are characteristic 
of inflammatory bowel diseases (IBD) 
such as Crohn’s disease. So Medzhitov 
suspected that mice less able to respond to 
bacterial products might end up better off.
Instead, mice deficient for Toll-like 
receptor (TLR) responses to bacterial 
products such as lipopolysaccharide (LPS) 
were more susceptible than wild-type 
mice to a colon-damaging chemical. The 
increased damage and death was not the 
result of bacterial invasion, as lymphocyte 
infiltration was low, and epithelial dam-
age and bleeding remained high when the 
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Protein-only prions
 
hen Stanley Prusiner proposed the protein-only hypothesis of prion 
infectivity, he envisioned a simple experiment. Make the protein in 
vitro, and infect the mouse. Now, Giuseppe Legname, Prusiner (University of 
California, San Francisco, CA), and colleagues have done just that, albeit with 
a lack of potency that has left some people in doubt.
The problem is that the most potent material—brain extract—is a mess. 
A misfolded version of the endogenous PrP protein emerged decades ago as the 
putative infectious agent. But in infected brains it is clumped in an insoluble 
amyloid form that is difficult to purify and impossible to crystallize. Thus, the 
exact nature of the most infectious form is a mystery. “The only measurable 
thing we have right now is the amount of 
 
 
 
-sheet,” says Legname. “We do not 
know the actual structure.”
His approach was to start with the recombinant version of a truncated form, 
known to be predisposed to forming amyloid, and select conditions that favored 
W
Prions from brain (squares) and two recombinant 
preparations (triangles) cause prion disease.
L
e
g
n
a
m
e
/
A
A
A
S
 
 
 
-sheet content. This preparation was injected into the brains of mice overexpressing a similarly truncated protein. Between 380 
and 660 d later, the mice showed disease symptoms, which could be serially transferred to other mice.
Some researchers believe that the test system is poised to become infectious, and the injection may be just one of many 
neurotoxic stresses that would eventually get it going (Couzin, 2004). Legname does acknowledge that “you may well need 
accessory factors in vivo”—factors that would only be transferred from brain extract not recombinant material. And even the 
most infectious conformation may be lost once the protein is injected into a host.
But Legname reminds the doubters that “yeast prion systems have established that the protein-only hypothesis is right,” 
although of course they lack the brain pathology of mammals. He remains confident that the “hundreds of different conditions” 
that the team is testing to increase infectivity will bring down the presymptomatic time and eventually allow disease initiation 
by recombinant protein in wild-type mice.
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same mice had antibiotics added to their 
regimen. Furthermore, wild-type mice 
died from chemical-induced damage when 
treated with antibiotics that completely 
eliminated commensal bugs.
Low doses of LPS or another TLR ligand 
rescued intestinal damage in the antibiotic-
treated wild-type mice, apparently by 
inducing protective cytokines and heat 
shock proteins. Such a regimen might be 
contemplated for the damaged digestive 
tracts of chemotherapy patients, who are 
given high doses of prophylactic antibiotics 
to back up their weakened immune systems.
In contrast to earlier conclusions by IBD 
researchers, Medzhitov says it is now clear 
that “the recognition of commensals is not 
just an unwanted side effect.” The body 
may use the influx of commensals into an 
intestinal wound as an indicator of damage. 
In internal organs lacking commensals, 
there appear to be endogenous ligands that 
signal similarly, and indeed Medzhitov has 
preliminary evidence that some of these 
also induce the TLR system. Whether a 
tissue repair system evolved to take on an 
immune defense duty, or vice versa, is now 
open to debate. 
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A colon without commensals (bottom) 
cannot repair damage.
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